CA52818-2 - 0x000000000000707F

Males & Females of Non-Childbearing Potential

Marvelous

* Stipend may pay up to reflected amount.
Start Date: 
September 16, 2026 - 3:15pm
End Date: 
November 12, 2026 - 9:15am

Study Details

Study Number: CA52818
Group Number: 2
Study Requirement: Healthy Normal Male and Female
Stipend: up to $6,000.00

Study Criteria

Age: 19 - 55
BMI: 0 - 0
Weight Restriction: minimum weight 0 lbs

Study Information

Indication: This investigational medication is being developed to treat inflammatory bowel disease.
Route of Administration: Injection IV infusion
Blood Draws: 12

Study Schedule

Schedule Type: Short stays with returns
Study Length: 2 Night Stay & 5 Returns

Screening Dates:

Event Day Event Date
Tuesday 9/8/2026
Wednesday 9/9/2026
Monday 9/14/2026
Tuesday 9/15/2026

Doctor Exam Dates:

Event Day Event Date
Tuesday 9/8/2026
Wednesday 9/9/2026
Monday 9/14/2026
Tuesday 9/15/2026

Study Dates:

Event Type Start Day Start Date End Day End Date Phase Site
Check-In Wednesday 9/16/2026 3:15:00 PM Friday 9/18/2026 10:45:00 AM 1 Lincoln
Return Wednesday 9/23/2026 8:45:00 AM Wednesday 9/23/2026 10:15:00 AM 1 Lincoln
Return Thursday 10/1/2026 8:45:00 AM Thursday 10/1/2026 10:15:00 AM 1 Lincoln
Return Thursday 10/15/2026 8:45:00 AM Thursday 10/15/2026 10:15:00 AM 1 Lincoln
Return Thursday 10/29/2026 8:45:00 AM Thursday 10/29/2026 10:15:00 AM 1 Lincoln
Return Thursday 11/12/2026 7:45:00 AM Thursday 11/12/2026 9:15:00 AM 1 Lincoln